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tigating EX-driven bone formation and regulation of osteoblast and
osteoclast activity. We propose that FSTL3 may also serve as a target to
develop therapeutic drugs for treating bone diseases.
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BONE SECRETED DICKKOPF-RELATED PROTEIN 1 AMELIORATES
OSTEOARTHRITIS IN MICE
T. Funck-Brentano, W. Bouaziz, C. Marty, V. Geoffroy, E. Hay,
M. Cohen-Solal;. Inserm U1132, Paris, France
Objective: Cartilage loss and subchondral bone changes are hallmarks
of osteoarthritis (OA). The family of the Wnt pathway is involved in the
regulation of bone and cartilage homeostasis. Our preliminary results
suggested that the Wnt/b-catenin pathway is mainly activated in bone
during OA, but the effect of the reduction of bone Wnt pathway on
cartilage remodeling are unknown. We here investigated the impact of
the inhibition of the Wnt pathway speciﬁcally in bone tissue during the
development of OA.
Methods: Joint instability induced by partial meniscectomy (MNX) was
performed in mice to promote OA. We investigated the impact of the
inhibition of bone Wnt pathway in OA development using mice over-
expressing Dkk1 in bone (2.3 Col1-Dkk1Tg) after MNX. The effects of
Dkk-1 in chondrocyte and osteoblast metabolismwere further assessed
using supernatant transfer and MMP expression.
Results: The Wnt/b-catenin pathway was activated in bone and carti-
lage, predominantly in osteocytes of subchondral bone and osteo-
phytes, but remained weak in articular cartilage throughout the
development of OA. The number of Dkk1 (þ) chondrocytes was high at
baseline (84.2  3.1%) and decreased markedly during the course of OA
from week 4 (14.4  3.8%) to week 6 (5.7  1.6%). At baseline, Dkk1-Tg
mice had lower bone volumewhich was further reduced in MNX knees.
Dkk1-Tg experienced a lower OA score than WT mice (5.1  0.63 vs 8.4
 0.6, p ¼ 0.002) independently of the expression of Dkk1 in chon-
drocytes. This was accompanied by a reduction of the subchondral bone
and osteophyte volume. However, addition of supernatant of osteo-
blasts derived from Dkk-1-Tg mice or in vitro addition of rhDkk1 in
chondrocytes promoted chondrocytic expression of MMP-3, -13 and
ADAMTS-4 while the supernatant of pre-exposed osteoblasts with Dkk1
decreased the expression of proteases. Because Dkk1-Tg osteoblasts
produced low VEGF, we tested whether VEGF could mediate the anti-
catabolic effect observed in vivo. Blocking VEGF in the supernatant of
osteoblast cultures reversed the expression of MMPs by chondrocytes.
Conclusion: We conﬁrm that Wnt is mainly activated in bone in OA
joints. Inhibition of Wnt pathway by Dkk1 overexpression in bone
decreased OA severity by reducing VEGF production. Targeting bone
could be a useful approach for the treatment of OA.
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CHIP IS A CRITICAL REGULATOR OF TRAF6 DEGRADATION AND
OSTEOCLAST FORMATION
D. Chen y, S. Li y, G. Xiao y, Z. Chang z. yRush Univ., Chicago, IL, USA;
z Tsinghua Univ., Beijing, China
Purpose: Bone tissue is constantly remodeled. Abnormal osteoclast
formation may result in bone disorders, such as osteoporosis, Paget’s
disease, and rheumatoid arthritis. Nuclear factor of kB (NF-kB) plays a
key role in osteoclast formation and bone resorption. A key event in NF-
kB signaling is the activation of an adaptor protein TRAF6. Once acti-
vated, TRAF6 further activates IKKb (I-kB kinase), which phosphorylates
I-kBa (the inhibitor of NF-kB), leading to its degradation. Carboxyl ter-
minus of Hsp70-interacting protein (CHIP) is an E3 ligase and regulates
the stability of several proteins which are involved in tumor growth and
metastasis. However, the role of CHIP in bone remodeling in vivo has not
been reported. The objective of this study is to investigate the role of
CHIP in regulation of bonemass and bone remodeling anddetermine the
molecular mechanism of CHIP in regulation of TRAF6 protein stability.
Methods: The bone phenotype of 1-month-old Chip-/- mice was
examined by histology, histomorphometry, mCT, and gene expression
analyses. The regulation of CHIP on TRAF6 degradation and the inhib-
ition of NF-kB signaling was examined by immunoprecipitation,
Western blotting, and ubiquitination assay.
Results: In this study, we found that deletion of Chip leads to osteopenic
phenotype. There was signiﬁcant reduction in bone volume (%, BV/TV,66% decrease) and bone mineral density (59% decrease) in Chip-/- mice.
Trabecular numbers (44% decrease), trabecular thickness (33%
decrease) were signiﬁcantly decreased in Chip-/- mice. In contrast, tra-
becular separation (1.7-fold increase) was signiﬁcantly increased in
Chip-/-mice. Higher structure model index (1.4-fold increase) and lower
connectivity density (75% decrease) were observed in Chip-/- mice,
suggesting more fragile bone when Chip gene is deleted. Cortical bone
volume (40% decrease) and bone mineral density (40% decrease) were
also signiﬁcantly reduced in Chip-/- mice. One major reason for the
osteopenic phenotype observed in Chip-/- mice could be due to the
increase in osteoclast formation. TRAP-positive osteoclast numbers
(1.6-fold increase) and osteoclast surface (1.5-fold increase) were sig-
niﬁcantly increased in Chip-/- mice. In vitro osteoclast formation assay
showed that there was 3.5-fold increase in osteoclast formation in
Chip-/-mice using osteoclast precursor cells isolated fromWTand Chip-/-
mice. Consistently bone resorption area was also increased in Chip-/-
mice, demonstrated by an in vitro bone resorption assay using bone
marrow cells derived from WT and Chip-/- mice. The expression of
osteoclast marker genes, such as Cathepsin K (7-fold increase), Mmp9
(16-fold increase), Trap (16-fold increase), and Nfatc1 (3-fold increase),
was signiﬁcantly increased after RANKL treatment in bone marrow cells
derived from Chip-/- mice. There was a signiﬁcant increase in TRAF6
protein levels in Chip-deﬁcient bone marrow cells. In contract, no
changes in TRAF6 mRNA levels were found in the same Chip-/- cells,
suggesting that CHIP may regulate TRAF6 protein stability. In a series of
in vitro studies we found that: 1) Interaction of endogenous CHIP with
TRAF6 was detected in RAW264.7 osteoclast-like cells. 2) The ubiq-
uitination of endogenous TRAF6 protein was reduced in Chip-/- bone
marrow cells. 3) The phosphorylation of IKKa/b and IkBa was sig-
niﬁcantly increased in Chip-/- bone marrow cells after RANKL stim-
ulation. 4) p65 nuclear translocation was enhanced in Chip-/- bone
marrow cells when the cells were treated with RANKL.
Conclusions: Our studies demonstrated that CHIP interacts with TRAF6
in osteoclast precursor cells and promotes TRAF6 ubiquitination and
proteasome degradation; subsequently inhibits NF-kB signaling and
regulates osteoclast formation. In Chip KOmice TRAF6 protein levels are
increased, leading to activation of osteoclast formation and signiﬁcant
bone loss.
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SPATIAL ASSOCIATION OF SUBCHONDRAL OSTEOSCLEROSIS WITH
ENHANCED MARROW IMMUNE CELL INFILTRATION, OSTEOCLAST
ACTIVITY AND CARTILAGE DEGENERATION IN HUMAN
OSTEOARTHRITIS
J. Geurts y, A. Patel z, B.E. Pippenger y, M.T. Hirschmann x,
M. M€uller-Gerbl z, V. Valderrabano y, T. H€ugle y. yUniv. Hosp. Basel, Basel,
Switzerland; zUniv. of Basel, Basel, Switzerland; xKantonspital-Baselland,
Bruderholz, Switzerland
Purpose: Osteosclerosis of subchondral bone is a pathological hallmark
of osteoarthritis (OA) and increasing evidence supports a pivotal and
active role of this tissue in the initiation and progression of disease in
experimental and human OA. The cellular and molecular regulation of
subchondral osteosclerosis remains poorly understood. Regulation of
bone remodeling by immune cells, termed osteoimmunology, has been
demonstrated in a number joint disorders including rheumatoid
arthritis and osteoporosis. In this study we investigated whether
osteoimmunological mechanisms might be involved in regulating
subchondral osteosclerosis in human OA.
Methods: Subchondral bonemineralization density (BMD) of explanted
OA tibial plateaus was mapped using computed tomography osteoab-
sorptiometry (CT-OAM) analysis. Areas having a subchondral BMD
below 800 or over 1200 Hounsﬁeld units were deﬁned to be non-
sclerotic and sclerotic, respectively. Using CT-OAM mapping, histo-
logical tissue sections were prepared from both areas (n ¼ 18 each).
Cartilage degeneration and subchondral bone area fraction were
determined using Mankin score and the ImageJ-plugin BoneJ, respec-
tively. Presence of immune cells in subchondral bone marrow tissue
was investigated using immunohistological and ﬂow cytometry analy-
ses for expression of CD3 (T-lymphocytes), CD20 (B-lymphocytes) and
CD68 (macrophages). Functional osteoclasts were identiﬁed by histo-
chemical staining for tartrate-resistant acid phosphatase (TRAP) activ-
ity. Outgrowth cultures of nonsclerotic and sclerotic bone were stained
for TRAP and alkaline phosphatase (ALP) activity. The effect of con-
ditioned medium from nonsclerotic and sclerotic subchondral bone
